Genistein Treatment Confers Protection against Gliopathy and Vasculopathy of the Diabetic Retina in Rats

Ultrastructural Pathology

Volumn 39, Issue 6, 2015, Pages 385-394

  Elgayar, Sanaa A M ^a   Eltony, Sohair A ^a   Sayed, Abdelrahman A ^a   Abdel Rouf, Maha M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

Author keywords

Capillaries; diabetic retinopathy; genistein; glia

Indexed keywords

GENISTEIN; PROTEIN KINASE INHIBITOR;

ANIMAL; CAPILLARY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GLIA; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; RAT; RETINA; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; CAPILLARIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; GENISTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROGLIA; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; RETINA;

EID: 84947043819     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2015.1045664     Document Type: Article

References (48)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med 1993;328: 1676-85.
2. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 2005;16(Suppl 1): S30-3.
3. Kelly DJ, Gilbert RE, Cox AJ, et al. Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 2001;12: 2098-107.
4. Elmarakby AA, Ibrahim AS, Faulkner J, Mozaffari MS, Liou GI et al. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice. Vasc Pharmacol 2011;55: 149-56.
5. Sadowska-Krowicka H, Mannick EE, Oliver PD, et al. Genistein and gut inflammation: Role of nitric oxide. Proc Soc Exp Biol Med 1998;217: 351-7.
6. Ibrahim AS, El-Shishtawy MM, Peña Jr A, Liou GI. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010;16: 2033-42.
7. Kamalden TA, Ji D, Fawcett RJ, Osborne NN. Genistein blunts the negative effect of ischaemia to the retina caused by an elevation of intraocular pressure. Ophthalmic Res 2011;45: 65-72.
8. Bagheri M, Rezakhani A, Nyström S, Turkina MV, Roghani M, Hammarström P, Mohseni S. Amyloid beta (1-40)- induced astrogliosis and the effect of genistein treatment in rat: A three-dimensional confocal morphometric and proteomic study. PLoS One 2013;8: e76526.
9. Kim JB, Song BW, Park S, et al. Alagebrium chloride, a novel advanced glycation end-product cross linkage breaker, inhibits neointimal proliferation in a diabetic rat carotid balloon injury model. Korean Circ J 2010;40: 520-6.
10. Han SY, So G, Jee YH, et al. Effect of retinoic acid in experimental diabetic nephropathy. Immunol and Cell Biol 2004;82: 568-76.
11. Pongsukwetchakul A, Kulaputana O, Patumraj S, Udayachalerm W. Genistein improves blood sugar and glycated hemoglobin levels in diabetic rats. Thai J Phys Sci 2007;20: 31-6.
12. Drury RAB, Wallington EA. Carelton s histology technique, 5th edition. Oxford: Oxford University Press, 1980.
13. Gupta PD. Ultrastructural study on semithin section. Sci Tools 1983;30: 6-7.
14. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000;41: 3561-8.
15. Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: Electroretinographical and morphologicalobservations. Exp Eye Res 2002;74: 615-25.
16. Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998;47: 815-20.
17. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000;41: 1971-80.
18. Diloreto Jr DA, Martzen MR, Del CC, et al. Müller cell changes precede photoreceptor cell degeneration in the age-related retinal degeneration of the Fischer 344 rat. Brain Res 1995;698: 1-14.
19. Eisenfeld AJ, Bunt-Milam AH, Sarthy PV. Müller cell expression of glial fibrillary acidic protein after genetic and experimental photoreceptor degeneration in the rat retina. Invest Ophthalmol Vis Sci 1984;25: 1321-8.
20. Wang X, Tay SS Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res 2000;132: 476-84.
21. Bignami A, Dahl D. The radial glia of Müller in the rat retina and their response to injury: An immunofluorescence study with antibodies to the glial fibrillary acidic (GFA) protein. Exp Eye Res 1979;28: 63-9.
22. Humphrey MF, Constable IJ, Chu Y, Wiffen S. A quantitative study of the lateral spread of Müller cell responses to retinal lesions in the rabbit. J Comp Neurol 1993;334: 545-58.
23. Verderber LC, Johnson W, Mucke L, Sarthy V. Differential regulation of a GFAP-lacZ transgene in retinal astrocytes and Müller cells. Invest Ophthalmol Vis Sci 1995; 36: 1137-43.
24. Grosche J, Grimm D, Clemens N, Reichenbach A. Retinal light damage vs. normal aging of rats: Altered morphology, intermediate filament expression, and nuclear organization of Müller (glial) cells. J Hirnforsch 1997;38: 459-70.
25. Zuo HS. Effects of different concentrations of insulin and glucose on the glycogenesis of retinal müller cells [dissertation]. Fuzhou, Fujian, China: Fujian Medical University, 2011.
26. Coffe V, Carbajal RC, Salceda R. Glycogen metabolism in the rat retina. J Neurochem 2004;88: 885-90.
27. Kuwabara T. Cogan DG Retinal glycogen. Am J Ophthalmol 1961;66: 680-8.
28. Mizuno K, Sato K. Reassessment of histochemistry of retinal glycogen. Exp Eye Res 1975;21: 489-97.
29. Poitry-Yamate CL, Tsacopoulos M. Glucose metabolism in freshly isolated Muller glial cells from a mammalian retina. J Comp Neurol 1992;320: 257-66.
30. Rungger-Brändle E, Kolb H, Niemeyer G. Histochemical demonstration of glycogen in neurons of the cat retina. Invest Ophthalmol Vis Sci 1996;37: 702-15.
31. Pfeiffer B, Grosche J, Reichenbach A, Hamprecht B. Immunocytochemical demonstration of glycogen phosphorylase in Muller (glial) cells of the mammalian retina. Glia 1994;12: 62-7.
32. Streit WJ, Kreutzberg GW. Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J Comp Neurol 1988;268: 248-63.
33. Kern TS, Engerman RL. Comparison of retinal lesions in alloxan diabetic rats and galactose-fed rats. Curr Eye Res 1994;13: 863-7.
34. Frank RN, Turczyn TJ, Das A. Pericyte coverage of retinal and cerebral capillaries. Invest Ophthalmol Vis Sci 1990;31: 999-1007.
35. Behl Y, Krothapalli P, Desta T, et al. Diabetes-enhanced tumor necrosis factor alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 2008;172: 1411-8.
36. Podesta F, Romeo G, Liu WH, et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 2000;156: 1025-32.
37. Trudeau K, Molina AJA, Roy S. High glucose induces mitochondrial morphology and metabolic changes in retinal Pericytes Investigative. Ophthalmol Vis Sci 2011;52: 8657-64.
38. Zheng L, Kern T. Role of nitric oxide, superoxide, peroxynitrite and poly(ADP-ribose) polymerase in diabetic retinopathy. Front Biosci 2009;14: 3974-87.
39. Zheng L, Howell SJ, Hatala DA, et al. Salicylate-based antiinflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes 2007;56: 337-45.
40. Ali TK, Matragoon S, Pillai BA, et al. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 2008;57: 889-98.
41. El-Remessy AB, Abou-Mohamed G, Caldwell RW, Caldwell RB. High glucose-induced tyrosine nitration in endothelial cells: Role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 2003;44: 3135-43.
42. El-Remessy AB, Behzadian MA, Abou-Mohamed G, et al. Experimental diabetes causes breakdown of the bloodretina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 2003;162: 1995-2004.
43. El-Remessy AB, Bartoli M, Platt DH, et al. Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 2005;118: 243-52.
44. Zhan X, Du Y, Crabb JS, et al. Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics 2007;7: 864-74.
45. Leal EC, Manivannan A, Hosoya K, et al. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 2007;48: 5257-65.
46. Zheng L, Du Y, Miller C, et al. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007;50: 1987-96.
47. Grigsby JG, Cardona SM, Pouw CE, et al. The role of microglia in diabetic retinopathy. J Ophthalmol 2014;2014: 705783.
48. Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012;61: 549-59.